ILMN Stock - Illumina Inc.

ILMN Stock Chart

ILMN Profile

Illumina, Inc. is a leading provider of advanced sequencing and array-based solutions tailored for genetic and genomic analysis. With a robust portfolio of products and services, the company facilitates genomic research and clinical applications across diverse markets, including life sciences, oncology, reproductive health, and agriculture. Illumina's technology supports the adoption of genomic solutions by offering instruments, consumables, and comprehensive genotyping and sequencing services.

Catering to a wide-ranging customer base, Illumina serves genomic research centers, academic institutions, government laboratories, and hospitals worldwide. Additionally, its products are integral to pharmaceutical, biotechnology, and commercial molecular diagnostic laboratories, as well as consumer genomics companies seeking to leverage genomic insights for personalized healthcare solutions.

The company operates a global distribution network, directly marketing its products in North America, Europe, Latin America, and the Asia-Pacific region. It also collaborates with life-science distributors across Europe, Asia-Pacific, Latin America, the Middle East, and Africa, ensuring widespread accessibility to its cutting-edge genomic technologies.

Founded in 1998 and headquartered in San Diego, California, Illumina continues to drive innovation in genetic and genomic analysis. With a steadfast commitment to advancing precision medicine and enhancing scientific discovery, the company remains at the forefront of genomic technology, pioneering new applications and expanding its global footprint in the evolving field of genomics.

ILMN Revenue Chart

ILMN Earnings

Analyst Ratings